|
MechanismTAG-72 antagonists |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with SCA Ventures, Inc.
0 Patents (Medical) associated with SCA Ventures, Inc.
100 Deals associated with SCA Ventures, Inc.
100 Translational Medicine associated with SCA Ventures, Inc.